Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: Analysis of Mexican patients included in a multicenter international clinical trial

Peginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: Analysis of Mexican patients included in a multicenter international clinical trial

Treatment with polyethylene glycol-modified interferon alfa-2a (peginterferon) alone produces significantly higher sustained antiviral responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection. We compared the efficacy and safety of peginterfer...

Full description

Bibliographic Details
Main Authors: Francisco Bosques-Padilla, MD, Rafael Trejo-Estrada, MD, Octaivio Campollo-Rivas, MD, Carlos Cortez-HernÁndez, MD, Margarita Dehesa-Violante, MD, Héctor Maldonado-Garza, MD, Raúl Pérez-Gómez, MD, Armando Cabrera-Valdespino, MD
Format: Article
Language:English
Published: Elsevier 2003-07-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis C
Peginterferon alfa-2a efficacy
Early prediction response
Treatment security.
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119321398

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119321398

Similar Items